Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Colistin to Prevent Ventilator-Associated Pneumonia in Patients With Acute Brain Injury
NCT06819462Recruiting
- Sponsor
- Southeast University
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of colistin in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Southeast University. Primary endpoint: Prevention of early Ventilator-Associated Pneumonia at 7 days. Started Apr 2025; status: recruiting.
02
Drugs
colistin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT06819462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06819462.